Interleukin-6 gene polymorphism (-174 G/C) is associated with toxoplasmic retinochoroiditis

Acta Ophthalmologica

Volumn 91, Issue 4, 2013, Pages

  Cordeiro, Cynthia A ^a,b,c   Moreira, Paula R ^a   Bessa, Thais F ^a   Costa, Germano C ^a   Dutra, Walderez O ^a,d   Campos, Wesley R ^a   Oréfice, Fernando ^c   Young, Lucy H ^b   Teixeira, Antônio L ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^c Brazilian Center of Visual Sciences   (Brazil)

^d Biosciences Division   (United States)

Author keywords

interleukin 6; polymorphism; toxoplasmosis; uveitis

Indexed keywords

GENOMIC DNA; INTERLEUKIN 6;

ADULT; ALLELE; ARTICLE; BRAZIL; CHORIORETINITIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; IL 6 GENE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; TOXOPLASMIC RETINOCHOROIDITIS; TOXOPLASMOSIS;

ADULT; ALLELES; ANIMALS; CHORIORETINITIS; DNA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENOTYPE; HUMANS; INTERLEUKIN-6; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TOXOPLASMOSIS, OCULAR;

EID: 84878470421     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12046     Document Type: Article

References (38)

1. Adán A, Sole M, Mateo C, Jean AS, &, Alforja S, (2012): Cytologic identification of Toxoplasma gondii from subretinal aspirate. Acta Ophthalmol 90: 392-393.
2. Albuquerque MC, Aleixo AL, Benchimol EI, Leandro AC, das Neves LB, Vicente RT, Bonecini-Almeida MdaG, &, Amendoeira MR, (2009): The IFN-gamma +874T/A gene polymorphism is associated with retinochoroiditis toxoplasmosis susceptibility. Mem Inst Oswaldo Cruz 104: 451-455.
3. Beaman MH, Hunter CA, &, Remington JS, (1994): Enhancement of intracellular replication of Toxoplasma gondii by IL-6. Interactions with IFN-gamma and TNF-alpha. J Immunol 153: 4583-4587.
4. Boyer KM, (1996): Diagnosis and treatment of congenital toxoplasmosis. Adv Pediatr Infect Dis 11: 449-467.
5. 2-induced apoptosis in ARPE-19 cells through the transcriptional regulation of apoptotic elements and downregulation of the p38 MAPK pathway. Acta Ophthalmol 89: 350-356.
6. Cordeiro CA, Moreira PR, Andrade MS, Dutra WO, Campos WR, Oréfice F, &, Teixeira AL, (2008a): Interleukin-10 gene polymorphism (-1082A/G) is associated with Toxoplasmic Retinochoroiditis. Invest Ophthalmol Vis Sci 49: 1979-1982.
7. Cordeiro CA, Moreira PR, Costa GC, Dutra WO, Campos WR, Oréfice F, &, Teixeira AL, (2008b): TNF-alpha gene polymorphism (-308G/A) and toxoplasmic retinochoroiditis. Br J Ophthalmol 92: 986-988.
8. Cordeiro CA, Moreira PR, Costa GC, Dutra WO, Campos WR, Oréfice F, &, Teixeira AL, (2008c): Interleukin-1 gene polymorphisms and toxoplasmic retinochoroiditis. Mol Vis 14: 1845-1849.
9. Diehl S, &, Rincon M, (2002): The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 39: 531-536.
10. Diehl S, Anguita J, Hoffmeyer A, Zapton T, Ihle JN, Fikrig E, &, Rincon M, (2000): Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity 13: 805-815.
11. Diehl S, Chow CW, Weiss L, et al., (2002): Induction of NFATc2 expression by interleukin 6 promotes T helper type 2 differentiation. J Exp Med 196: 39-49.
12. Dilek K, Ozçimen AA, Saricaoǧlu H, Saba D, Yücel A, Yurtkuran M, Yurtkuran M, &, Oral HB, (2009): Cytokine gene polymorphism in Behçet's disease and their association with clinical and laboratory findings. Clin Exp Rheumatol 27: 73-78.
13. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, &, Woo P, (1998): The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102: 1369-1376.
14. Grossman R, Krueger J, Yourish D, et al., (1989): Interleukin-6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86: 6367-6371.
15. Henderly DE, Genstler AJ, Smith RE, &, Rao NA, (1987): Changing patterns of uveitis. Am J Ophthalmol 103: 131-136.
16. Holland GN, (2003): Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol 136: 973-988.
17. Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, &, Hurme M, (2001): Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL-6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease. Rheumatology 40: 656-661.
18. Iacopetta B, Grieu F, &, Joseph D, (2004): The -174 G/C gene polymorphism in interleukin 6 is associated with an aggressive breast cancer phenotype. Br J Cancer 90: 419-422.
19. Jabs DA, Nussenblatt RB, &, Rosenbaum JT,; Standardization of Uveitis Nomenclature (SUN) Working Group (2005): Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140: 509-516.
20. Jebbari H, Roberts CW, Ferguson DJ, Bluethmann H, &, Alexander J, (1998): A protective role for IL-6 during early infection with Toxoplasma gondii. Parasite Immunol 20: 231-239.
21. Klein W, Tromm A, Griga T, et al., (2001): The polymorphism at position -174 of the IL-6 gene is not associated with inflammatory bowel disease. Eur J Gastroenterol Hepatol 13: 45-47.
22. Lappin MR, Dow SW, Reif JS, &, Chavkin MJ, (1997): Elevated interleukin 6 activity in aqueous humor of cats with uveitis. Vet Immunol Immunopathol 58: 17-26.
23. Licastro F, Pedrini S, Caputo L, Annoni G, Davis LJ, Ferri C, Casadei V, &, Grimaldi LM, (2000): Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? J Neuroimmunol 103: 97-102.
24. Licastro F, Grimaldi LM, Bonafè M, et al., (2003): Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain. Neurobiol Aging 24: 921-926.
25. Lyons RE, Anthony JP, Ferguson DJ, Byrne N, Alexander J, Roberts F, &, Roberts CW, (2001): Immunological studies of chronic ocular toxoplasmosis: up-regulation of major histocompatibility complex class I and transforming growth factor beta and a protective role for interleukin-6. Infect Immun 69: 2589-2595.
26. McCannel CA, Holland GN, Helm CJ, Cornell PJ, Winston JV, &, Rimmer TG, (1996): Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol 121: 35-46.
27. Menezo V, Bond SK, Towler HM, Kuo NW, Baharlo B, Wilson AG, &, Lightman S, (2006): Cytokine gene polymorphisms involved in chronicity and complications of anterior uveitis. Cytokine 35: 200-206.
28. Moreira PR, Lima PM, Sathler KO, Imanishi SA, Costa JE, Gomes RS, Gollob KJ, &, Dutra WO, (2007): Interleukin-6 expression and gene polymorphism are associated with severity of periodontal disease in a sample of Brazilian individuals. Clin Exp Immunol 148: 119-126.
29. Murray PI, Hoekzema R, van Haren MA, de Hon FD, &, Kijlstra A, (1990): Aqueous humor interleukin-6 levels in uveitis. Invest Ophthalmol Vis Sci 31: 917-920.
30. Nagineni CN, Detrick B, &, Hooks JJ, (2000): Toxoplasma gondii infection induces gene expression and secretion of interleukin 1 (IL-1), IL-6, granulocyte-macrophage colony-stimulating factor, and intercellular adhesion molecule 1 by human retinal pigment epithelial cells. Infect Immun 68: 407-410.
31. Oréfice F, (2005): Uveíte: Clínica e Cirúrgica: Texto e Atlas, 2a ed. Rio de Janeiro: Cultura Médica 1484-1485.
32. Roberts F, &, McLeod R, (1999): Pathogenesis of toxoplasmic retinochoroiditis. Parasitol Today 15: 51-57.
33. Silver JS, Stumhofer JS, Passos S, Ernst M, &, Hunter CA, (2011): IL-6 mediates the susceptibility of glycoprotein 130 hypermorphs to Toxoplasma gondii. J Immunol 187: 350-360.
34. Suzuki Y, Yang Q, Conley FK, Abrams JS, &, Remington JS, (1994): Antibody against interleukin-6 reduces inflammation and numbers of cysts in brains of mice with toxoplasmic encephalitis. Infect Immun 62: 2773-2778.
35. Suzuki Y, Rani S, Liesenfeld O, et al., (1997): Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice. Infect Immun 65: 2339-2345.
36. Taylor JJ, Preshaw PM, &, Donaldson PT, (2004): Cytokine gene polymorphism and immunoregulation in periodontal disease. Periodontol 2000 35: 158-182.
37. Terry CT, Loukaci V, &, Green FR, (2000): Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 24: 18138-18144.
38. Van Snick J, (1990): Interleukin-6: an overview. Annu Rev Immunol 8: 253-278.